Global Markets for Media, Sera and Reagents in Biotechnology

April 30, 2012

Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR MEDIA, SERA AND REAGENTS IN BIOTECHNOLOGY (BIO014G) from BCC Research (www.bccresearch.com), global revenues for media, sera and reagents used in biotechnology totaled nearly $2.8 billion in 2011 and are expected to reach $4.2 billion in 2016, a compound annual growth rate (CAGR) of 8.8%.

Reagents accounted for nearly $1.2 billion in revenue in 2011 and the segment is expected to reach $2 billion in 2016, a CAGR of 11.3%.

Media totaled nearly $900 million in 2011 and should experience a CAGR of 9.4% to reach $1.4 billion in 2016.

Sera, worth $678 million in 2011, should reach nearly $784 million in 2016, a CAGR of 2.9%.

Demand for cell culture products, namely media, sera and reagents, is increasing, with the increasing demand for biopharmaceuticals. Cell culture, a crucial component of the life-sciences industry, has witnessed major development during the past three decades. R&D spending, along with increasing competition, patent expiries, new technologies, and an international marketplace are moving the cell-culture process in a new direction. As cell-culture technologies evolved, a number of disciplines such as cell biology, genetic engineering, protein chemistry, genomics, and chemical engineering have been successfully incorporated into the cell-culture field.

Increased demand for stem-cell therapeutics, vaccines, recombinant therapeutics, and other biotherapeutics are the major factors driving growth within the cell-culture market. The success of monoclonal antibodies (mAbs) has increased demand from contract manufacturers and consequently the market for cell-culture products in the contract segment also has increased significantly.

This study contributes to the areas of market growth in the cell-culture industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest.

In addition to BIO014G, BCC also has published BIO095A, BIO096A, BIO097A, and BIO098A. These reports cover media, sera and reagents used in biotechnology with focuses, respectively, on the U.S., European, Asian, and emerging markets regions.

To Contact us, click here  

Global Markets for Media, Sera and Reagents in Biotechnology( BIO014G )
Publish Date: Apr 2012    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.